Dr. Reddy’s Laboratories Limited (NYSE:RDY – Get Rating) has received a consensus rating of “Hold” from the seven analysts that are currently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, one has issued a hold rating, one has given a buy rating and one has given […]
Dr. Reddy’s Laboratories Limited (NYSE:RDY – Get Rating) – Equities research analysts at Zacks Research reduced their Q1 2024 earnings estimates for Dr. Reddy’s Laboratories in a research note issued on Wednesday, May 24th. Zacks Research analyst E. Bagri now expects that the company will earn $0.71 per share for the quarter, down from their […]
Causeway Capital Management LLC increased its holdings in Dr. Reddy’s Laboratories Limited (NYSE:RDY – Get Rating) by 17.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 100,822 shares of the company’s stock after purchasing an additional 14,853 shares during the period. […]
Portland Hill Asset Management Ltd cut its position in shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY – Get Rating) by 2.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 16,731 shares of the company’s stock after selling 411 shares during the period. Dr. Reddy’s Laboratories accounts for approximately 2.4% of Portland Hill Asset […]
Dr. Reddy’s Laboratories Limited (NYSE:RDY – Get Rating) – Equities researchers at Zacks Research lowered their Q2 2024 earnings estimates for shares of Dr. Reddy’s Laboratories in a report issued on Wednesday, May 24th. Zacks Research analyst E. Bagri now forecasts that the company will earn $0.76 per share for the quarter, down from their […]